Facilitated By

San Antonio Medical Foundation

News

  • Solis Mammography Announces Acquisition of Avestēe Women's Imaging Centers in San Antonio

    Biotechnology · Clinical Trials & Medical Discoveries ... Solis Mammography Announces Acquisition of Avestēe Women's Imaging Centers in San Antonio.

  • RemeGen reports Phase III success for disitamab vedotin | Biotechnology | The Pharmaletter

    16 December 2024. More on this story... UCB and Biogen's dapirolizumab pegol paves new path for SLE treatment · Biotechnology.

  • Shareholders do not share Bicycle cheer | The Pharmaletter

    ... Biotechnology. 16 December 2024. More on this story... Novartis extends radiopharma lead with new collab · Pharmaceutical.

  • Ibrance Plus Frontline Standard Therapy Delays Progression by 15 Months in HER2, HR ...

    SAN ANTONIO – Pfizer's CDK4/6 inhibitor Ibrance (palbociclib) added to ... Biotech · Leapfrog Bio to Begin Phase II Trial of Synthetic Lethal ...

  • Two startups nab $50K in San Antonio holiday pitch competition

    The San Antonio company launched in May and currently has 150 subscribers for its services. ... biotechnology research and development.